elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Communities
Lab
API & MCP
Pricing
Log in
Sign up
Home
/
Subjects
/
Angiotensin II
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Angiotensin II
RIS
0.002
(Research Intensity Score)
Papers
258
Top papers
Signaling pathways of chronic kidney diseases, implications for therapeutics
2022 · 436 citations
Reactive oxygen species in hypertension
2024 · 126 citations
Doctoral Dissertation
2019 · 998 citations
SLC31A1 loss depletes mitochondrial copper and promotes cardiac fibrosis
2025 · 41 citations
Sodium Homeostasis, a Balance Necessary for Life
2023 · 91 citations
Newest papers
Sex differences in neurogenic hypertension: estrogen modulation of NADPH oxidase signaling in the rostral ventrolateral medulla
2026
Thromboxane A2-Driven Vascular Hyperreactivity in Cadmium-Induced Hypertension: Role of Oxidative Stress and Therapeutic Implications
2026
Dual-strategy; complexation-based solid dispersion for enhancing the solubility and dissolution rate of candesartan cilexetil
2026
Effects of esaxerenone add‐on therapy versus angiotensin II receptor blocker dose escalation on albuminuria and blood pressure in hypertensive patients with type 2 diabetes: An exploratory randomized study
2026
Distinct Molecular Signatures Underlying Myocardial Fibrosis Regression with Sacubitril/Valsartan: A Proteomic Substudy of the REVERSE-LVH Trial
2026
A sample from the 100 top papers behind Angiotensin II.
Create a free account to browse them all →
Angiotensin II's history
Research intensity over time
Explore Angiotensin II's full history
Hover any year for its value and switch resolutions with a free account. Personal adds monthly detail and the historical-intensity (HRI) line.
Create a free account
Already have an account?
Log in
to explore the data.
Close ✕
Angiotensin II's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link